by Jordana Choucair | Jun 14, 2022 | Life Sciences
Senator Amy Klobuchar and Representative Katie Porter asked the Federal Trade Commission (FTC) to investigate whether Janssen Pharmaceuticals and Bristol Myers Squibb Co. coordinated “parallel” price increases on Xarelto and Eliquis. The letter noted that,...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved the first treatment for alopecia treatment that restores hair growth. The agency said that two trials showed that Eli Lilly & Co.’s Olumiant helped roughly 40 percent of the 1,2000 trial participants achieve...
by Jordana Choucair | Jun 14, 2022 | Life Sciences
An amendment to the Senate’s latest FDA user fee proposal calls on infant formula manufacturers to notify the agency within five business days of a disruption to their supply chain, an attempt to better guard against future formula shortages. The amendment...
by Jordana Choucair | Jun 14, 2022 | Opioid/Substance Use Disorders
A new report found that fatal drug overdoses rose nearly 15 percent in Kentucky last year, surpassing 2,000 deaths and setting a record death toll in the state. According to the report, released by the Kentucky Justice and Public Safety Cabinet and the Office of Drug...
by Jordana Choucair | Jun 14, 2022 | Payers
eHealth released a survey indicating that 13 percent of Medicare Advantage (MA) enrollees had a claim or pre-authorization request denied. Of those, 43 percent said their plan told them the claim was excluded from coverage. Another 15 percent said coverage was denied...
by Jordana Choucair | Jun 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) released briefing documents indicating that Moderna’s and Pfizer-BioNTech’s COVID-19 vaccines are both effective and safe for children 5 years old and younger. The FDA documents found that the Pfizer-BioNTech vaccine was...
Recent Comments